Tedjaseputra, A., Potter, N., Jovanovic, J., Ivey, A., Runglall, M., Villiers, W., Aucken, P., Lim, M., Arumugam, T., Grimwade, O., Gilkes, A., Canham, J., Johnson, S., Thomas, I., Ommen, H., Overgaard, U., Spearing, R., Dennis, M., O'Nions, J., King, A., Cahalin, P., Mehta, P., Taussig, D., Solomon, E., Burnett, A., Freeman, S., Knapper, S., Wei, A., Othman, J., Russell, N., Dillon, R. (2025). FLT3-ITD NGS-MRD refines risk stratification in NPM1 and FLT3 co-mutated AML beyond NPM1 PCR-MRD: Analysis of the UK NCRI AML17 and AML19 trials. Blood. https://doi.org/10.1182/blood-2025-345